These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 11827905)

  • 41. Effectiveness of discontinuing antibiotic treatment after three days versus eight days in mild to moderate-severe community acquired pneumonia: randomised, double blind study.
    el Moussaoui R; de Borgie CA; van den Broek P; Hustinx WN; Bresser P; van den Berk GE; Poley JW; van den Berg B; Krouwels FH; Bonten MJ; Weenink C; Bossuyt PM; Speelman P; Opmeer BC; Prins JM
    BMJ; 2006 Jun; 332(7554):1355. PubMed ID: 16763247
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Impact of HIV-1 status on the radiological presentation and clinical outcome of children with WHO defined community-acquired severe pneumonia.
    Jeena PM; Minkara AK; Corr P; Bassa F; McNally LM; Coovadia HM; Fox M; Hamer DH; Thea D
    Arch Dis Child; 2007 Nov; 92(11):976-9. PubMed ID: 17595201
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Non-treatment of children with community health worker-diagnosed fast-breathing pneumonia in rural Malawi: exploratory subanalysis of a prospective cohort study.
    King C; Colbourn T; Mankhambo L; Beard J; Hay Burgess DC; Costello A; Izadnegahdar R; Lufesi N; Mwansambo C; Nambiar B; Johnson ES; Platt RW; Mukanga D; McCollum ED
    BMJ Open; 2016 Nov; 6(11):e011636. PubMed ID: 27852705
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Treating idiopathic pulmonary fibrosis with the addition of co-trimoxazole: an economic evaluation alongside a randomised controlled trial.
    Wilson EC; Shulgina L; Cahn AP; Chilvers ER; Parfrey H; Clark AB; Twentyman OP; Wilson AM
    Pharmacoeconomics; 2014 Jan; 32(1):87-99. PubMed ID: 24307539
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antibiotic strategies for developing countries: experience with acute respiratory tract infections in Pakistan.
    Qazi SA
    Clin Infect Dis; 1999 Feb; 28(2):214-8. PubMed ID: 10064229
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Double-blind, randomized study of the efficacy and safety of oral pharmacokinetically enhanced amoxicillin-clavulanate (2,000/125 milligrams) versus those of amoxicillin-clavulanate (875/125 milligrams), both given twice daily for 7 days, in treatment of bacterial community-acquired pneumonia in adults.
    File TM; Lode H; Kurz H; Kozak R; Xie H; Berkowitz E;
    Antimicrob Agents Chemother; 2004 Sep; 48(9):3323-31. PubMed ID: 15328092
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Single dose pefloxacin compared with multiple dose co-trimoxazole in cystitis.
    Petersen EE; Wingen F; Fairchild KL; Halfhide A; Hendrischk A; Links M; Schad M; Scholz HR; Schürmann N; Siegmann S
    J Antimicrob Chemother; 1990 Oct; 26 Suppl B():147-52. PubMed ID: 2258341
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Simplified antibiotic regimens for the management of clinically diagnosed severe infections in newborns and young infants in first-level facilities in Karachi, Pakistan: study design for an outpatient randomized controlled equivalence trial.
    Zaidi AK; Tikmani SS; Sultana S; Baloch B; Kazi M; Rehman H; Karimi K; Jehan F; Ahmed I; Cousens S
    Pediatr Infect Dis J; 2013 Sep; 32 Suppl 1(Suppl 1 Innovative Treatment Regimens for Severe Infections in Young Infants):S19-25. PubMed ID: 23945571
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Different lengths of treatment with co-trimoxazole for acute uncomplicated urinary tract infections in women.
    Trienekens TA; Stobberingh EE; Winkens RA; Houben AW
    BMJ; 1989 Nov; 299(6711):1319-22. PubMed ID: 2513939
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Efficacy and safety of temafloxacin versus those of amoxicillin in hospitalized adults with community-acquired pneumonia.
    Carbon C; Léophonte P; Petitpretz P; Chauvin JP; Hazebroucq J
    Antimicrob Agents Chemother; 1992 Apr; 36(4):833-9. PubMed ID: 1323954
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Short-course antimicrobial therapy for paediatric respiratory infections (SAFER): study protocol for a randomized controlled trial.
    Pernica J; Harman S; Kam A; Bailey J; Carciumaru R; Khan S; Fulford M; Thabane L; Slinger R; Main C; Smieja M; Loeb M
    Trials; 2018 Feb; 19(1):83. PubMed ID: 29391051
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ambulatory Treatment of Fast Breathing in Young Infants Aged <60 Days: A Double-Blind, Randomized, Placebo-Controlled Equivalence Trial in Low-Income Settlements of Karachi.
    Tikmani SS; Muhammad AA; Shafiq Y; Shah S; Kumar N; Ahmed I; Azam I; Pasha O; Zaidi AK
    Clin Infect Dis; 2017 Jan; 64(2):184-189. PubMed ID: 27941119
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical Effectiveness of Co-trimoxazole vs. Amoxicillin in the Treatment of Non-Severe Pneumonia in Children in India: A Randomized Controlled Trial.
    Rajesh SM; Singhal V
    Int J Prev Med; 2013 Oct; 4(10):1162-8. PubMed ID: 24319556
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Efficacy and safety of azithromycin 1 g once daily for 3 days in the treatment of community-acquired pneumonia: an open-label randomised comparison with amoxicillin-clavulanate 875/125 mg twice daily for 7 days.
    Paris R; Confalonieri M; Dal Negro R; Ligia GP; Mos L; Todisco T; Rastelli V; Perna G; Cepparulo M
    J Chemother; 2008 Feb; 20(1):77-86. PubMed ID: 18343748
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Trimethoprim-sulfamethoxazole (co-trimoxazole) for the prevention of relapses of Wegener's granulomatosis. Dutch Co-Trimoxazole Wegener Study Group.
    Stegeman CA; Tervaert JW; de Jong PE; Kallenberg CG
    N Engl J Med; 1996 Jul; 335(1):16-20. PubMed ID: 8637536
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Co-trimoxazole or multivitamin multimineral supplement for post-discharge outcomes after severe anaemia in African children: a randomised controlled trial.
    Maitland K; Olupot-Olupot P; Kiguli S; Chagaluka G; Alaroker F; Opoka RO; Mpoya A; Walsh K; Engoru C; Nteziyaremye J; Mallewa M; Kennedy N; Nakuya M; Namayanja C; Kayaga J; Nabawanuka E; Sennyondo T; Aromut D; Kumwenda F; Musika CW; Thomason MJ; Bates I; von Hensbroek MB; Evans JA; Uyoga S; Williams TN; Frost G; George EC; Gibb DM; Walker AS;
    Lancet Glob Health; 2019 Oct; 7(10):e1435-e1447. PubMed ID: 31537373
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparing pharmacokinetics of amoxicillin given twice or three times per day to children older than 3 months with pneumonia.
    Fonseca W; Hoppu K; Rey LC; Amaral J; Qazi S
    Antimicrob Agents Chemother; 2003 Mar; 47(3):997-1001. PubMed ID: 12604533
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Challenges in the design of antibiotic equivalency studies: the multicenter equivalency study of oral amoxicillin versus injectable penicillin in children aged 3-59 months with severe pneumonia.
    Hibberd PL; Patel A;
    Clin Infect Dis; 2004 Aug; 39(4):526-31. PubMed ID: 15356816
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Early use of corticosteroids in infants with a clinical diagnosis of Pneumocystis jiroveci pneumonia in Malawi: a double-blind, randomised clinical trial.
    Newberry L; O'Hare B; Kennedy N; Selman A; Omar S; Dawson P; Stevenson K; Nishihara Y; Lissauer S; Molyneux E
    Paediatr Int Child Health; 2017 May; 37(2):121-128. PubMed ID: 28145162
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pre- and post-exposure prophylaxis of experimental Burkholderia pseudomallei infection with doxycycline, amoxicillin/clavulanic acid and co-trimoxazole.
    Sivalingam SP; Sim SH; Jasper LC; Wang D; Liu Y; Ooi EE
    J Antimicrob Chemother; 2008 Mar; 61(3):674-8. PubMed ID: 18192684
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.